Umbilical Cord Blood Transplantation in India – An Overview

Umbilical Cord Blood Transplantation in India

With approximately 72000 births daily, the availability of a donated umbilical cord is abundant. India has emerged as the preferred destination for medical treatments where in cord blood has the potential to be a crucial element in hematopoietic stem cell transplantation’s. As such a planned development in public cord blood banking would provide the required boost to medical tourism enabling India to achieve its objective of becoming a “global health destination”. Only 0.25 % is India’s share in the global percentage in cord blood based surgical treatment.

The UCB transplantation in India is in its infancy. Very few reports are available for application in hematological disorders and none for metabolic disorders. Number of transplantations that has happened in India related to UCB is only approximately 32 patients.

Considering a large number of patients born with blood-related disorders in the country, these transplantation’s are comparatively few, mainly because of cost prohibition, lack of sufficient UCB depository and because public UCB banks are in the early stage of development. The compatibility of procuring UCB from international depositories too has been a deterrent.

In India, there are thousands of patients with blood-related disorders who could benefit from Bone Marrow Transplantation. It is reported in 2010 that number of cases of Leukemia in India is estimated 104, 239 which is projected to be 117,649 in 2015 and 132,574 in 2020. Leukemia is the most common childhood Cancer, being 25 to 40% of all childhood

Cancers with 60-85% being acute lymphoid leukemia. An estimated 20 million carriers and 10,000 children are born each year with Thalassemia. A plastic Anemia incidence in the western world is estimated to be around 2 per million populations, where as it is as high as 6 to 8 per million populations in India and other Asian countries.

Advantages of umbilical cord blood (UCB) Transplantation:

  • Umbilical cord blood is an abundant source of stem cells and comes with risk to mother or infant.
  • Since collection occurs after birth of a full term normal infant, UCB is not associated with any ethical concerns and it an age old process.
  • There is low viral contamination of UCB including cytomegalovirus and Epstein-Barr virus.
  • UCB, cryo preserved and banked, is available on demand particularly for patients with unstable disease.
  • To date, no malignant transformation of infused UCB has been observed.
  • Frozen UCB can be easily shipped and thawed for use when needed.
  • This modality of stem cell transplant is an acceptable norm of treatment worldwide and as such is covered by insurance.

In Mycord we believe to give the best of the services to our client by:

  • Timely Availability
  • Affordability
  • Maintaining Internationally acceptable quality standards
  • Building awareness

Leave a Reply

Your email address will not be published. Required fields are marked *


Still Have Questions?


Need answers? We are here to help. Our Cord Blood Educators will be with you every step of the way.

CALL NOW 1800 103 3001


Order a free information packet now and see how easy it is to protect your loved ones.